TGFB1 and cardiomyopathy: This review will discuss mechanisms of chemotherapy-induced cardiomyopathy in TNBC patients and also highlight TGF-β signaling as an emerging pathway of therapeutic interest for the prevention of chemotherapy-induced cardiotoxic effects.